Arizona State Retirement System Has $36.52 Million Position in CVS Health Corporation $CVS

Arizona State Retirement System lifted its holdings in shares of CVS Health Corporation (NYSE:CVS) by 1.5% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 353,014 shares of the pharmacy operator’s stock after buying an additional 5,257 shares during the period. Arizona State Retirement System’s holdings in CVS Health were worth $36,519,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the stock. Handelsbanken Fonder AB raised its stake in shares of CVS Health by 83.6% during the 2nd quarter. Handelsbanken Fonder AB now owns 1,089,694 shares of the pharmacy operator’s stock worth $112,729,000 after purchasing an additional 496,124 shares in the last quarter. BNP Paribas grew its stake in shares of CVS Health by 105.2% in the second quarter. BNP Paribas now owns 49,971 shares of the pharmacy operator’s stock valued at $5,154,000 after buying an additional 25,617 shares in the last quarter. Legal & General Group Plc raised its position in CVS Health by 0.3% during the fourth quarter. Legal & General Group Plc now owns 9,309,182 shares of the pharmacy operator’s stock worth $738,777,000 after acquiring an additional 31,249 shares in the last quarter. State Street Corp lifted its stake in CVS Health by 2.1% in the fourth quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator’s stock valued at $4,776,182,000 after acquiring an additional 1,245,457 shares during the last quarter. Finally, Deutsche Bank AG grew its position in shares of CVS Health by 28.4% in the 4th quarter. Deutsche Bank AG now owns 4,666,495 shares of the pharmacy operator’s stock valued at $370,333,000 after acquiring an additional 1,031,998 shares during the period. Institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

Shares of NYSE CVS traded down $0.63 during trading hours on Tuesday, reaching $96.11. 4,195,902 shares of the stock were exchanged, compared to its average volume of 8,264,494. The firm has a market capitalization of $122.93 billion, a price-to-earnings ratio of 25.43, a P/E/G ratio of 0.94 and a beta of 0.59. The stock’s fifty day simple moving average is $100.65 and its 200 day simple moving average is $90.35. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. CVS Health Corporation has a 52 week low of $69.51 and a 52 week high of $110.68.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, beating analysts’ consensus estimates of $1.87 by $0.71. The firm had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The company’s revenue for the quarter was up 7.3% on a year-over-year basis. During the same period in the prior year, the firm posted $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Sell-side analysts predict that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health’s dividend payout ratio (DPR) is currently 70.37%.

Analysts Set New Price Targets

CVS has been the topic of a number of research analyst reports. Weiss Ratings raised shares of CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, August 5th. Piper Sandler restated an “overweight” rating on shares of CVS Health in a research note on Wednesday, August 26th. Wells Fargo & Company lifted their target price on CVS Health from $103.00 to $123.00 and gave the stock an “overweight” rating in a research note on Monday, July 13th. Argus boosted their target price on CVS Health from $104.00 to $114.00 and gave the stock a “buy” rating in a report on Wednesday, August 19th. Finally, Sanford C. Bernstein increased their price target on CVS Health from $94.00 to $106.00 and gave the company an “outperform” rating in a research note on Tuesday, May 12th. Twenty-two investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $106.83.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.